Olugbade TA - Search Results

1

Inter-individual variation in imatinib disposition: any role for prevalent variants of CYP1A2, CYP2C8, CYP2C9, and CYP3A5 in Nigerian CML patients?

Adehin A, Adeagbo BA, Kennedy MA, Bolaji OO, Olugbade TA, Bolarinwa RA, Durosinmi MA. Adehin A, et al. Among authors: olugbade ta. Leuk Lymphoma. 2019 Jan;60(1):216-221. doi: 10.1080/10428194.2018.1466291. Epub 2018 May 9. Leuk Lymphoma. 2019. PMID: 29741432

2

Population Pharmacokinetics of Imatinib in Nigerians With Chronic Myeloid Leukemia: Clinical Implications for Dosing and Resistance.

Adeagbo BA, Olugbade TA, Durosinmi MA, Bolarinwa RA, Ogungbenro K, Bolaji OO. Adeagbo BA, et al. Among authors: olugbade ta. J Clin Pharmacol. 2017 Dec;57(12):1554-1563. doi: 10.1002/jcph.953. Epub 2017 Jun 15. J Clin Pharmacol. 2017. PMID: 28618035

3

Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia.

Adeagbo BA, Bolaji OO, Olugbade TA, Durosinmi MA, Bolarinwa RA, Masimirembwa C. Adeagbo BA, et al. Among authors: olugbade ta. J Clin Pharm Ther. 2016 Oct;41(5):546-51. doi: 10.1111/jcpt.12424. Epub 2016 Jul 18. J Clin Pharm Ther. 2016. PMID: 27426203

4

Bidirectional Pharmacokinetic Interaction Between Amodiaquine and Pioglitazone in Healthy Subjects.

Edema O, Adeagbo BA, Adehin A, Olugbade TA. Edema O, et al. Among authors: olugbade ta. J Clin Pharmacol. 2018 Aug;58(8):1061-1066. doi: 10.1002/jcph.1108. Epub 2018 Apr 17. J Clin Pharmacol. 2018. PMID: 29663414

5

Pharmacokinetics and bioavailability of drotaverine in humans.

Bolaji OO, Onyeji CO, Ogundaini AO, Olugbade TA, Ogunbona FA. Bolaji OO, et al. Among authors: olugbade ta. Eur J Drug Metab Pharmacokinet. 1996 Jul-Sep;21(3):217-21. doi: 10.1007/BF03189716. Eur J Drug Metab Pharmacokinet. 1996. PMID: 8980918

6

Antimicrobial constituents of the leaves of Acalypha wilkesiana and Aacalypha hispida.

Adesina SK, Idowu O, Ogundaini AO, Oladimeji H, Olugbade TA, Onawunmi GO, Pais M. Adesina SK, et al. Among authors: olugbade ta. Phytother Res. 2000 Aug;14(5):371-4. doi: 10.1002/1099-1573(200008)14:5<371::aid-ptr625>3.0.co;2-f. Phytother Res. 2000. PMID: 10925407

7

Clinical evaluation of Acalypha ointment in the treatment of superficial fungal skin diseases.

Oyelami OA, Onayemi O, Oladimeji FA, Ogundaini AO, Olugbade TA, Onawunmi GO. Oyelami OA, et al. Among authors: olugbade ta. Phytother Res. 2003 May;17(5):555-7. doi: 10.1002/ptr.1161. Phytother Res. 2003. PMID: 12748998 Clinical Trial.

8

Petersaponins III and IV, triterpenoid saponins from Petersianthus macrocarpus.

Olugbade TA, Ogundaini A, Birlirakis N, Païs M, Martin MT. Olugbade TA, et al. J Nat Prod. 2000 May;63(5):716-9. doi: 10.1021/np990638s. J Nat Prod. 2000. PMID: 10843600

9

Prieurianoside, a protolimonoid glucoside from the leaves of Trichilia prieuriana.

Olugbade TA, Adesanya SA. Olugbade TA, et al. Phytochemistry. 2000 Aug;54(8):867-70. doi: 10.1016/s0031-9422(99)00374-x. Phytochemistry. 2000. PMID: 11014280

10

Distribution of iridiod glucosides and anti-oxidant compounds in Spathodea campanulata parts.

Elusiyan CA, Ani NC, Adewunmi CO, Olugbade TA. Elusiyan CA, et al. Among authors: olugbade ta. Afr J Tradit Complement Altern Med. 2011;8(1):27-33. doi: 10.4314/ajtcam.v8i1.60491. Epub 2010 Oct 2. Afr J Tradit Complement Altern Med. 2011. PMID: 22238480 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters